Sun-Hee Lee

Title: Innovations of Sun-Hee Lee in Inflammatory Disease Treatment

Introduction

Sun-Hee Lee is an accomplished inventor based in Wonju, South Korea. He has made significant contributions to the field of medical science, particularly in the treatment of inflammatory diseases and cancer. His innovative work has led to the development of a unique polypeptide that holds promise for therapeutic applications.

Latest Patents

Sun-Hee Lee holds 1 patent for his invention titled "Isolated polypeptides used for treatment of inflammatory diseases and inhibiting cancer metastasis." This invention relates to a polypeptide derived from a highly conserved region of transmembrane proteins, specifically CD99 and its family members. The polypeptide has shown potential in inhibiting the extravasation of white blood cells and the growth and metastasis of cancer cells. Additionally, the invention includes a polynucleotide coding for the polypeptide, a vector containing it, and a transformant transformed by the vector. Furthermore, it provides pharmaceutical compositions for preventing or treating inflammatory diseases and cancer.

Career Highlights

Sun-Hee Lee is currently associated with Supadelixir Inc., where he continues to advance his research and development efforts. His work is characterized by a strong focus on innovative solutions for complex medical challenges.

Collaborations

Sun-Hee Lee collaborates with notable colleagues, including Jang-Hee Hahn and Hyun-Mi Ju, who contribute to his research endeavors. Their combined expertise enhances the potential impact of their work in the medical field.

Conclusion

Sun-Hee Lee's innovative contributions to the treatment of inflammatory diseases and cancer through his patented polypeptide exemplify the importance of research and development in medical science. His work continues to inspire advancements in therapeutic solutions.